• Most Recent
  • Most Relevant
130 results
Alert
COVID-19: Disruption to Art Transactions
Alert
The Internal Market Bill, the EU Withdrawal Agreement and the risk of no deal on the EU-UK future relationship
Article
New expansion of foreign direct investments control regime in France and the impact on French biotech companies
Alert
Climate Change Disputes Take Center Stage at Paris Arbitration Week (PAW)
Alert
COVID-19: Acquisition of more than 10% voting rights by non-EU/EEA foreign investors in French listed companies will be subject to fast-track FDI review
Article
Paris Court of Appeal refuses to set aside ICC award against non-party (Kabab-Ji v Kout Food Group)
Alert
Dallah Revisited: The French and English Courts in Conflict Again Regarding Arbitral Jurisdiction Over Non-Signatories
Paris
Insight
France hopes for recovery after COVID deal dip
French M&A activity has suffered steep falls because of COVID-19, but green shoots are emerging as lockdown measures ease
France
Insight
Foreign direct investment reviews 2025: France
French FDI screening continues to focus on foreign investments involving medical and biotech activities, food security activities or the treatment, storage and transmission of sensitive data. The nuclear ecosystem is subject to very close scrutiny.
France
Insight
Foreign direct investment reviews 2024: France
French FDI screening continues to focus on foreign investments involving medical and biotech activities, food security activities or the treatment, storage and transmission of sensitive data. The nuclear ecosystem is subject to very close scrutiny.